Home
About Leecan
Overview of Leecan
History
Corporate Culture
Honor
Responsibility
Product
Marketed Products
Regulatory Review
In Development
Production and Research Platform
Research and Development Platform
Production and Operation
Quality Assurance
CMO/CDMO
News regulations
Investor
Careers
Talent Concept
People in leecan
Recruitment
Career development
Contact Us
Cooperation
Supplier Cooperation
Recruitment
Pharmacovigilance
CMO/CDMO
EN
/
CN
Home
About Leecan
Overview of Leecan
History
Corporate Culture
Honor
Responsibility
Product
Marketed Products
Regulatory Review
In Development
Production and Research Platform
Research and Development Platform
Production and Operation
Quality Assurance
CMO/CDMO
News regulations
Investor
Careers
Talent Concept
People in leecan
Recruitment
Career development
Contact Us
Cooperation
Supplier Cooperation
Recruitment
Pharmacovigilance
CMO/CDMO
Issue 6: Focusing on regulatory updates in generics, new drug development, and more
Release time：2026-07-06
share:
Previous article：Issue 7: Recent Key NMPA/CDE Policies Summary
next article：Issue 5: Focusing on the revised GCP and other new pharmaceutical regulations
Back to list
You may also want to read
The Zhongdanyuan laboratory was put into use to master the core technology independently!
2021.11.15
Obtaining drug production approval for inhalation of compound ipratropium bromide solution!
2025.01.06
Nanjing Leecan production base was inaugurated victoriously!
2022.08.01
